Heartbeam Inc — Cash Flow (NASDAQ:BEAT) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Cash from operating activities 3.23 M9.95 M12.09 M14.47 M 15.23 M Cash from investing activities ——256 K201 K 184 K Cash from financing activities 16.4 M350 K24.99 M866 K 11.51 M Free cash flow 3.23 M9.95 M11.84 M14.27 M 15.05 M

Notícias

HeartBeam nomeia Bryan Humbarger como diretor comercial

HeartBeam appoints Bryan Humbarger as chief commercial officer

Bernstein eleva preço-alvo das ações da Beam Therapeutics para US$ 37 com base nas perspectivas do programa AATD

Bernstein raises Beam Therapeutics stock price target to $37 on AATD program outlook

UBS inicia cobertura da Beam Therapeutics com classificação Neutra

Beam Therapeutics stock initiated with Neutral rating by UBS

Ações da HeartBeam disparam após H.C. Wainwright dobrar preço-alvo com liberação do FDA

HeartBeam stock soars as H.C. Wainwright doubles price target on FDA clearance

BEAT Secures FDA Nod for First Cable-Free At-Home 12-Lead ECG System

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.05%

E.U.A. - Ações fecharam o pregão em alta e o Índice Dow Jones Industrial Average avançou 1,05%

Oracle, Synopsys, Heartbeam, Planet Labs And Adobe: Why These 5 Stocks Are On Investors' Radars Today - Adobe (NASDAQ:ADBE), HeartBeam (NASDAQ:BEAT)